Suppr超能文献

[钙拮抗剂:基于新证据的当前及未来应用。钙通道阻滞剂与单片复方制剂]

[Calcium antagonists: current and future applications based on new evidence. Calcium channel blockers and single-pill combination].

作者信息

Okura Takafumi, Higaki Jitsuo

机构信息

Department of Integrated Medicine and Informatics, Ehime University Graduate School of Medicine, Japan.

出版信息

Clin Calcium. 2010 Jan;20(1):61-8.

Abstract

Ca channel blocker (CCB) is widely used as an anti-hypertensive and anti-ischemic heart disease drug in Japan. CCB or angiotensin receptor antagonist (ARB) is selected as a first line anti-hypertensive drug. However, mono-therapy is often insufficient and combination therapy is needed to achieve the adequate blood pressure control. Hypertensive patients are also sometimes combined with dyslipidemia. In these reasons, a single pill combination of CCB and ARB or statin play an important role in hypertensive and anti-atherosclerotic therapy.

摘要

钙通道阻滞剂(CCB)在日本被广泛用作抗高血压和抗缺血性心脏病药物。CCB或血管紧张素受体拮抗剂(ARB)被选为一线抗高血压药物。然而,单一疗法往往不足,需要联合治疗以实现充分的血压控制。高血压患者有时还合并血脂异常。基于这些原因,CCB与ARB或他汀类药物的单片复方制剂在高血压和抗动脉粥样硬化治疗中发挥着重要作用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验